Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis-Reference-Cited by-同舟云学术

Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis

Published:2021-10-05 Issue:2 Volume:36 Page:573-576
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Chen Jia^ORCID,Zhao Ai-lin,Duan Ming-hui^ORCID,Cai Hao^ORCID,Gao Xue-min^ORCID,Liu Ting,Sun Jian,Liang Zhi-yong,Zhou Dao-bin^ORCID,Cao Xin-xin^ORCID,Li Jian^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-021-01439-3.pdf

Reference15 articles.

1. Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010;116:1919–23.

2. Haroche J, Charlotte F, Arnaud L, von Deimling A, Helias-Rodzewicz Z, Hervier B, et al. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012;120:2700–3.

3. Durham BH, Lopez Rodrigo E, Picarsic J, Abramson D, Rotemberg V, De Munck S, et al. Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms. Nat Med. 2019;25:1839–42.

4. Diamond EL, Durham BH, Haroche J, Yao Z, Ma J, Parikh SA, et al. Diverse and targetable kinase alterations drive histiocytic neoplasms. Cancer Disco. 2016;6:154–65.

5. Durham BH. Molecular characterization of the histiocytoses: Neoplasia of dendritic cells and macrophages. Semin Cell Dev Biol. 2019;86:62–76.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review and a case of rare Rosai-Dorfman disease;Biotechnology & Biotechnological Equipment;2024-09-10

2. Liver involvement with Langerhans cell histiocytosis in adults;The Oncologist;2024-07-27

3. Current State of Targeted Therapy in Adult Langerhans Cell Histiocytosis and Erdheim–Chester Disease;Targeted Oncology;2024-07-11

4. Lenalidomide and dexamethasone for Rosai-Dorfman disease: a single arm, single center, prospective phase 2 study;eClinicalMedicine;2024-07

5. Cladribine chemotherapy of multifocal, multisystemic form of Rosai–Dorfman disease: literature review and case report;Oncohematology;2024-04-03